Latest filing published 03 Jun 2025 for REGENXBIO Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alexandra Glucksmann: trading record in brief
Alexandra Glucksmann (board member) discloses dealings in 2 companies, chiefly Editas Medicine, Inc. and REGENXBIO Inc. Over a trading history stretching from 23 August 2016 to 30 May 2025, the count stands at 11 filings.
On the market, this insider has only sold: 4 sales, €159k in total. Besides market trades, the filings include 4 share grants and 3 option exercises.
Most recently, on 3 June 2025, the filings show a share grant in REGENXBIO Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alexandra Glucksmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,768 shares0Common StockSEC:0001562180-25-004349:0
- 4,790 shares0Common StockSEC:0001562180-24-004653:0
- 3,486 shares0Common StockSEC:0001562180-23-004891:0
- 3,010 shares0Common StockSEC:0001562180-22-004876:0
4 of 4 declarations
